Fatty acid breath test values in the malabsorption range in cancer patients

W. E. Delaney, R. K. Stuart, David S Ettinger

Research output: Contribution to journalArticle

Abstract

Fatty acid absorption breath tests (FABT) were found to be abnormal in most subjects in a group of cancer patients selected to exclude common causes of abnormal lipid absorption, including chemotherapy and radiation therapy. The breast tests were abnormal in both quality (delayed peak in 9 of 10 patients) and quantity (reduced maximum peak in 5 of 10 patients) of fatty acid absorption. Retrospective separation of patients into 2 groups (normal or low maximum peak height FABT), either at a common time after the start of the test or at each individual's maximum peak height FABT regardless of time, was significant at 0.005 and 0.001, respectively. The low maximum peak heights were in the range of the malabsorption syndrome. Further studies of pancreatic function and fat malabsorption are warranted before the abnormal results can be ascribed to altered intermediary metabolism or peripheral utilization of lipids.

Original languageEnglish (US)
Pages (from-to)122-128
Number of pages7
JournalNutrition and Cancer
Volume3
Issue number3
StatePublished - 1982

Fingerprint

breath tests
Breath Tests
malabsorption
Fatty Acids
fatty acids
neoplasms
Neoplasms
lipids
Malabsorption Syndromes
Lipids
radiotherapy
drug therapy
breasts
Breast
Radiotherapy
Fats
testing
Drug Therapy
metabolism

ASJC Scopus subject areas

  • Food Science
  • Medicine (miscellaneous)
  • Oncology

Cite this

Fatty acid breath test values in the malabsorption range in cancer patients. / Delaney, W. E.; Stuart, R. K.; Ettinger, David S.

In: Nutrition and Cancer, Vol. 3, No. 3, 1982, p. 122-128.

Research output: Contribution to journalArticle

@article{491f17916f2d40038c4a40805af81b49,
title = "Fatty acid breath test values in the malabsorption range in cancer patients",
abstract = "Fatty acid absorption breath tests (FABT) were found to be abnormal in most subjects in a group of cancer patients selected to exclude common causes of abnormal lipid absorption, including chemotherapy and radiation therapy. The breast tests were abnormal in both quality (delayed peak in 9 of 10 patients) and quantity (reduced maximum peak in 5 of 10 patients) of fatty acid absorption. Retrospective separation of patients into 2 groups (normal or low maximum peak height FABT), either at a common time after the start of the test or at each individual's maximum peak height FABT regardless of time, was significant at 0.005 and 0.001, respectively. The low maximum peak heights were in the range of the malabsorption syndrome. Further studies of pancreatic function and fat malabsorption are warranted before the abnormal results can be ascribed to altered intermediary metabolism or peripheral utilization of lipids.",
author = "Delaney, {W. E.} and Stuart, {R. K.} and Ettinger, {David S}",
year = "1982",
language = "English (US)",
volume = "3",
pages = "122--128",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "3",

}

TY - JOUR

T1 - Fatty acid breath test values in the malabsorption range in cancer patients

AU - Delaney, W. E.

AU - Stuart, R. K.

AU - Ettinger, David S

PY - 1982

Y1 - 1982

N2 - Fatty acid absorption breath tests (FABT) were found to be abnormal in most subjects in a group of cancer patients selected to exclude common causes of abnormal lipid absorption, including chemotherapy and radiation therapy. The breast tests were abnormal in both quality (delayed peak in 9 of 10 patients) and quantity (reduced maximum peak in 5 of 10 patients) of fatty acid absorption. Retrospective separation of patients into 2 groups (normal or low maximum peak height FABT), either at a common time after the start of the test or at each individual's maximum peak height FABT regardless of time, was significant at 0.005 and 0.001, respectively. The low maximum peak heights were in the range of the malabsorption syndrome. Further studies of pancreatic function and fat malabsorption are warranted before the abnormal results can be ascribed to altered intermediary metabolism or peripheral utilization of lipids.

AB - Fatty acid absorption breath tests (FABT) were found to be abnormal in most subjects in a group of cancer patients selected to exclude common causes of abnormal lipid absorption, including chemotherapy and radiation therapy. The breast tests were abnormal in both quality (delayed peak in 9 of 10 patients) and quantity (reduced maximum peak in 5 of 10 patients) of fatty acid absorption. Retrospective separation of patients into 2 groups (normal or low maximum peak height FABT), either at a common time after the start of the test or at each individual's maximum peak height FABT regardless of time, was significant at 0.005 and 0.001, respectively. The low maximum peak heights were in the range of the malabsorption syndrome. Further studies of pancreatic function and fat malabsorption are warranted before the abnormal results can be ascribed to altered intermediary metabolism or peripheral utilization of lipids.

UR - http://www.scopus.com/inward/record.url?scp=0020421823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020421823&partnerID=8YFLogxK

M3 - Article

C2 - 7134008

AN - SCOPUS:0020421823

VL - 3

SP - 122

EP - 128

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 3

ER -